Clinical Trials on Urethral Urothelial Carcinoma in United Kingdom
Total 11040 results
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Gilead SciencesActive, not recruitingMetastatic Urothelial CarcinomaUnited States
-
Imperial College London4D pharma plcActive, not recruitingMelanoma | Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Renal Cancer | Urethral Cancer | Uterine CancerUnited Kingdom
-
National Cancer Institute (NCI)RecruitingStage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 | Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
Principia Biopharma, a Sanofi CompanyTerminatedSolid Tumors | Metastatic Urothelial Carcinoma & Renal Pelvis & UreterSpain, United States
-
Brigham and Women's HospitalNot yet recruitingMuscle Invasive Bladder Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
Incyte CorporationCompletedUC (Urothelial Cancer)United States, Netherlands, Spain, Denmark, Belgium, Israel, Italy, Germany, France, Japan, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseRecruitingUrothelial Carcinoma | Non-Invasive Bladder Urothelial CarcinomaUnited States
-
Fox Chase Cancer CenterTerminatedStage III Bladder Cancer | Distal Urethral Cancer | Proximal Urethral Cancer | Squamous Cell Carcinoma of the Bladder | Urethral Cancer Associated With Invasive Bladder Cancer | Stage II Bladder CancerUnited States
-
Astellas Pharma Global Development, Inc.Seagen Inc.Approved for marketingLocally Advanced or Metastatic Urothelial Carcinoma (UC)United States
-
Genentech, Inc.TerminatedUrothelial CarcinomaKorea, Republic of, United States, Canada, United Kingdom, Belgium
-
Taiho Oncology, Inc.Merck Sharp & Dohme LLCActive, not recruitingAdvanced and Metastatic Urothelial CancerSpain, United States, France
-
National Cancer Institute (NCI)RecruitingMetastatic Urothelial Carcinoma | Stage IV Bladder Cancer AJCC v8 | Platinum-Resistant Urothelial CarcinomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedHigh Grade Upper Tract Urothelial CarcinomaUnited States
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, France, Belgium, Israel, Spain, United Kingdom, Korea, Republic of, Taiwan, Australia, Netherlands, Japan, Germany, Ukraine, Canada, Ireland, Italy, Poland, Russian Federation
-
British Urology Researchers in Surgical TrainingAction Bladder Cancer UK; The Urology Foundation; Test Evaluation Research Group...CompletedUrothelial CarcinomaUnited Kingdom
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedMetastatic Urothelial CarcinomaUnited States
-
University of UtahExelixisActive, not recruitingBladder Cancer | Metastatic Urothelial CarcinomaUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar TherapeuticsRecruitingLocally Advanced or Metastatic Urothelial CarcinomaKorea, Republic of, United States, Taiwan, Australia, United Kingdom, France, Greece, Italy, Belgium, Spain, Canada, Denmark, Germany
-
University of MichiganCompletedUrinary Tract Urothelial CarcinomaUnited States
-
European Association of Urology Research FoundationLaborie Medical Technologies Inc.RecruitingAnterior Urethral Stricture, MaleSpain, United Kingdom, Norway, Belgium, Italy
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedUC (Urothelial Cancer)United States, Spain, Hungary, Israel, United Kingdom, Korea, Republic of, Taiwan, Denmark, France, Netherlands, Italy, Canada, Japan, Turkey, Germany, Ireland, Australia, Russian Federation
-
QED Therapeutics, Inc.Helsinn Healthcare SATerminatedUpper Tract Urothelial Carcinomas | Urothelial Bladder CancerUnited States, France, Canada, Spain, Italy, Belgium, Germany, Netherlands, United Kingdom, Bulgaria, Greece
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingProstate Cancer | Urothelial Carcinoma | Stage IV Bladder Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Bladder Carcinoma | Metastatic Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Locally Advanced Bladder Urothelial Carcinoma | Metastatic Transitional Cell CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterTerminatedBladder Cancer | Urothelial CancerUnited States
-
Flare Therapeutics Inc.RecruitingAdvanced Solid Tumors Cancer | Advanced Urothelial Carcinoma | Open Label | Oral Drug AdministrationUnited States
-
Royal Devon and Exeter NHS Foundation TrustKing's College Hospital NHS Trust; Portsmouth Hospitals NHS Trust; North Bristol... and other collaboratorsRecruitingBladder Cancer | Urolithiasis | Bladder Outlet ObstructionUnited Kingdom
-
Weill Medical College of Cornell UniversityNeoTX Therapeutics Ltd.WithdrawnUrothelial CarcinomaUnited States
-
University of FloridaCompletedUrothelial CarcinomaUnited States
-
Case Comprehensive Cancer CenterCompletedUrothelial CarcinomaUnited States
-
Case Comprehensive Cancer CenterNot yet recruitingUrothelial CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterNot yet recruitingUrothelial CarcinomaUnited States
-
University of WashingtonTerminatedUrothelial CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterCompletedUrothelial CarcinomaUnited States
-
Yousef ZakhariaPfizer; University of IowaActive, not recruitingUrothelial CarcinomaUnited States
-
University of Michigan Rogel Cancer CenterTerminatedUrothelial CarcinomaUnited States
-
4D pharma plcWithdrawnUrothelial CarcinomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCActive, not recruitingRecurrent Bladder Carcinoma | Stage I Bladder Cancer | Stage 0a Bladder Urothelial Carcinoma | Stage 0is Bladder Urothelial CarcinomaUnited States
-
Wellspect HealthCareCompletedLower Urinary Tract Symptoms | Bladder Outlet ObstructionUnited States, Netherlands, Poland, United Kingdom
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen Inc.Not yet recruitingBladder Cancer | Urothelial Carcinoma Bladder | High Grade Urothelial CarcinomaUnited States
-
Bristol-Myers SquibbCompletedUrothelial CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteEndo PharmaceuticalsCompletedUrothelial CarcinomaUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Urethral CancerUnited States
-
Daiichi Sankyo, Inc.Bristol-Myers Squibb; AstraZenecaActive, not recruitingBreast Cancer | Urothelial CarcinomaUnited States, Spain, Italy, Belgium, France, Germany, United Kingdom
-
Arjun Balar, MDHoosier Cancer Research Network; Roche-GenentechTerminatedUrothelial CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterMayo Clinic; Hartford HospitalActive, not recruitingUrothelial CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingBladder Cancer | Urethral Cancer | Urachal CancerUnited States
-
State University of New York - Upstate Medical...Unknown
-
University Hospital, GhentCompletedUrologic Diseases | Surgery | Urethral StrictureBelgium, United States, Argentina, China, Mexico, Portugal, Spain, United Kingdom